Drug Shortage Report for MYLAN-BUPRENORPHINE/NALOXONE
Report ID | 7392 |
Drug Identification Number | 02408090 |
Brand name | MYLAN-BUPRENORPHINE/NALOXONE |
Common or Proper name | BUPRENORPHINE/NALOXONE |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | BUPRENORPHINE NALOXONE |
Strength(s) | 2MG 0.5MG |
Dosage form(s) | TABLET |
Route of administration | SUBLINGUAL |
Packaging size | 100BT |
ATC code | N07BC |
ATC description | DRUGS USED IN ADDICTIVE DISORDERS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2018-07-03 |
Actual start date | 2018-06-26 |
Estimated end date | Unknown |
Actual end date | 2019-09-17 |
Shortage status | Resolved |
Updated date | 2019-09-18 |
Company comments | discontinued in ID 94044. Last lot 3085355 exp 2019-05-31 |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v83 | 2018-02-02 | English | Compare |
v82 | 2018-01-31 | French | Compare |
v81 | 2018-01-31 | English | Compare |
v80 | 2018-01-29 | French | Compare |
v79 | 2018-01-29 | English | Compare |
v78 | 2018-01-26 | French | Compare |
v77 | 2018-01-26 | English | Compare |
v76 | 2018-01-24 | French | Compare |
v75 | 2018-01-24 | English | Compare |
v74 | 2018-01-22 | French | Compare |
v73 | 2018-01-22 | English | Compare |
v72 | 2018-01-19 | French | Compare |
v71 | 2018-01-19 | English | Compare |
v70 | 2018-01-17 | French | Compare |
v69 | 2018-01-17 | English | Compare |
v68 | 2018-01-15 | French | Compare |
v67 | 2018-01-15 | English | Compare |
v66 | 2018-01-12 | French | Compare |
v65 | 2018-01-12 | English | Compare |
v64 | 2018-01-10 | French | Compare |